<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35840817</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1619-7089</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European journal of nuclear medicine and molecular imaging</Title><ISOAbbreviation>Eur J Nucl Med Mol Imaging</ISOAbbreviation></Journal><ArticleTitle>2-[<sup>18</sup>F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee.</ArticleTitle><Pagination><StartPage>3599</StartPage><EndPage>3606</EndPage><MedlinePgn>3599-3606</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00259-022-05913-7</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Verger</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Universit&#xe9; de Lorraine, 54000, Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barthel</LastName><ForeName>Henryk</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Leipzig University, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolboom</LastName><ForeName>Nelleke</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraioli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Nuclear Medicine, University College London (UCL), London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchin</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nuclear Medicine Unit, Department of Medicine - DIMED, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Nathalie L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Berckel</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, UMC, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boellaard</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, UMC, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brendel</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre of Neurodegenerative Diseases (DZNE), Site Munich, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekmekcioglu</LastName><ForeName>Ozgul</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Nuclear Medicine Dept, Sisli Hamidiye Etfal Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semah</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Nuclear Medicine Department, University Hospital, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traub-Weidinger</LastName><ForeName>Tatjana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Weehaeghe</LastName><ForeName>Donatienne</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morbelli</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Ospedale Policlinico San Martino, Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guedj</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut Fresnel, Nuclear Medicine Department, APHM, CNRS, Timone Hospital, CERIMED, Aix Marseille Univ, Centrale Marseille, 264 rue Saint Pierre, 13005, Marseille, France. eric.guedj@ap-hm.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Nucl Med Mol Imaging</MedlineTA><NlmUniqueID>101140988</NlmUniqueID><ISSNLinking>1619-7070</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>
  AV has received speaker honoraria from GE Healthcare and Philips.   HB has received reader honoraria from LMI and speaker honoraria from AAA/Novartis.   FF has received speaker honoraria and receives research funding from Siemens Healthineers.   SM has received speaker honoraria from GE Healthcare, Roche, and LMI and is an advisor of LMI.   EG has received consultant and speaker honoraria from GE Healthcare and CIS Bio International; and consultant honoraria from Advanced Accelerator Applications.   The other authors declare that they have no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35840817</ArticleId><ArticleId IdType="pmc">PMC9286958</ArticleId><ArticleId IdType="doi">10.1007/s00259-022-05913-7</ArticleId><ArticleId IdType="pii">10.1007/s00259-022-05913-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guedj E, Verger A, Cammilleri S. PET imaging of COVID-19: the target and the number. Eur J Nucl Med Mol Imaging. 2020;47:1636&#x2013;1637. doi: 10.1007/s00259-020-04820-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04820-z</ArticleId><ArticleId IdType="pmc">PMC7163172</ArticleId><ArticleId IdType="pubmed">32303786</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbelli S, Ekmekcioglu O, Barthel H, Albert NL, Boellaard R, Cecchin D, et al. COVID-19 and the brain: impact on nuclear medicine in neurology. Eur J Nucl Med Mol Imaging. 2020;47:2487&#x2013;2492. doi: 10.1007/s00259-020-04965-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04965-x</ArticleId><ArticleId IdType="pmc">PMC7375837</ArticleId><ArticleId IdType="pubmed">32700058</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;jiac136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleki K, Banazadeh M, Saghazadeh A, Rezaei N. The involvement of the central nervous system in patients with COVID-19. Rev Neurosci. 2020;31:453&#x2013;456. doi: 10.1515/revneuro-2020-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0026</ArticleId><ArticleId IdType="pubmed">32463395</ArticleId></ArticleIdList></Reference><Reference><Citation>the Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel, Toniolo S, Scarioni M, Di Lorenzo F, Hort J, Georges J, et al. Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care. Bonanni L, editor. J Alzheimers Dis. 2021;82:883&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">34092646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kas A, Soret M, Pyatigoskaya N, Habert M-O, Hesters A, Le Guennec L, et al. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study. Eur J Nucl Med Mol Imaging. 2021;48:2543&#x2013;2557. doi: 10.1007/s00259-020-05178-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05178-y</ArticleId><ArticleId IdType="pmc">PMC7810428</ArticleId><ArticleId IdType="pubmed">33452633</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, Schroeter N, Bormann T, Thurow J, Wagner D, Frings L, et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med. 2021;62:910&#x2013;915. doi: 10.2967/jnumed.121.262128.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262128</ArticleId><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilensky JA, Foley P, Gilman S. Children and encephalitis lethargica: a historical review. Pediatr Neurol. 2007;37:79&#x2013;84. doi: 10.1016/j.pediatrneurol.2007.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2007.04.012</ArticleId><ArticleId IdType="pubmed">17675021</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al. COVID-19&#x2013;related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. 2021;13:eabf8396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1:e290&#x2013;e299. doi: 10.1016/S2666-5247(20)30144-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30144-0</ArticleId><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27.e1. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Masson M, Lan&#xe7;on C, Richieri R, Guedj E. The neuroinflammatory pathways of post-SARS-CoV-2 psychiatric disorders. L&#x2019;Enc&#xe9;phale. 2021;47:399&#x2013;400. doi: 10.1016/j.encep.2021.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.encep.2021.08.001</ArticleId><ArticleId IdType="pubmed">34593237</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Lazarini F, Morbelli S, Ceccaldi M, Hautefort C, Kas A, et al. Long COVID and the brain network of Proust&#x2019;s madeleine: targeting the olfactory pathway. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27:1196&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164472</ArticleId><ArticleId IdType="pubmed">34015528</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbelli S, Chiola S, Donegani MI, Arnaldi D, Pardini M, Mancini R, et al. Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson&#x2019;s disease (PD) do not overlap. Eur J Nucl Med Mol Imaging [Internet]. 2022 [cited 2022 Jan 19]; Available from: https://link.springer.com/10.1007/s00259-021-05666-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727173</ArticleId><ArticleId IdType="pubmed">34984501</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48(9):2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021;48:3187&#x2013;3197. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressing A, Bormann T, Blazhenets G, Schroeter N, Walter LI, Thurow J, et al. Neuropsychological profiles and cerebral glucose metabolism in neurocognitive Long COVID-syndrome. J Nucl Med. 2021;jnumed.121.262677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9258569</ArticleId><ArticleId IdType="pubmed">34649946</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer PT, Hellwig S, Blazhenets G, Hosp JA. Molecular imaging findings on acute and long-term effects of COVID-19 on the brain: a systematic review. J Nucl Med. 2022;63(7):971&#x2013;980. doi: 10.2967/jnumed.121.263085.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.263085</ArticleId><ArticleId IdType="pmc">PMC9258567</ArticleId><ArticleId IdType="pubmed">35177424</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand A, Campion J-Y, Lepine A, Bosdure E, Luciani L, Cammilleri S, et al. Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series. Eur J Nucl Med Mol Imaging. 2022;49:913&#x2013;920. doi: 10.1007/s00259-021-05528-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05528-4</ArticleId><ArticleId IdType="pmc">PMC8376118</ArticleId><ArticleId IdType="pubmed">34414470</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Manca R, De Marco M, Ince PG, Venneri A. Heterogeneity in regional damage detected by neuroimaging and neuropathological studies in older adults with COVID-19: a cognitive-neuroscience systematic review to inform the long-term impact of the virus on neurocognitive trajectories. Front Aging Neurosci. 2021;13:646908. doi: 10.3389/fnagi.2021.646908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.646908</ArticleId><ArticleId IdType="pmc">PMC8209297</ArticleId><ArticleId IdType="pubmed">34149394</ArticleId></ArticleIdList></Reference><Reference><Citation>Maguire EA, Woollett K, Spiers HJ. London taxi drivers and bus drivers: a structural MRI and neuropsychological analysis. Hippocampus. 2006;16:1091&#x2013;1101. doi: 10.1002/hipo.20233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.20233</ArticleId><ArticleId IdType="pubmed">17024677</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, et al. EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3. Eur J Nucl Med Mol Imaging [Internet]. 2021 [cited 2021 Dec 10]; Available from: https://link.springer.com/10.1007/s00259-021-05603-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8803744</ArticleId><ArticleId IdType="pubmed">34882261</ArticleId></ArticleIdList></Reference><Reference><Citation>Verger A, Kas A, Dudouet P, Goehringer F, Salmon-Ceron D, Guedj E. Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience. Eur J Nucl Med Mol Imaging. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8941296</ArticleId><ArticleId IdType="pubmed">35320385</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Tastevin M, Verger A, Richieri R. Brain PET imaging in psychiatric disorders. Ref Module Biomed Sci [Internet]. Elsevier; 2021 [cited 2021 Dec 10]. p. B9780128229606000000. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780128229606000909.</Citation></Reference><Reference><Citation>Guedj E, Campion J, Horowitz T, Barthelemy F, Cammilleri S, Ceccaldi M. The impact of COVID-19 lockdown on brain metabolism. Hum Brain Mapp. 2022;43:593&#x2013;597. doi: 10.1002/hbm.25673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.25673</ArticleId><ArticleId IdType="pmc">PMC8720189</ArticleId><ArticleId IdType="pubmed">34636103</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpin S, Martineau P, Levasseur M-A, Lambert R. Modeling the effects of age and sex on normal pediatric brain metabolism using 18 F-FDG PET/CT. J Nucl Med. 2018;59:1118&#x2013;1124. doi: 10.2967/jnumed.117.201889.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.117.201889</ArticleId><ArticleId IdType="pubmed">29284674</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, Mei N, Wu P-Y, Huang C-C, et al. Cerebral micro-structural changes in COVID-19 patients &#x2013; an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Verger A, Doyen M, Campion JY, Guedj E. The pons as reference region for intensity normalization in semi-quantitative analysis of brain 18FDG PET: application to metabolic changes related to ageing in conventional and digital control databases. EJNMMI Res. 2021;11:31. doi: 10.1186/s13550-021-00771-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13550-021-00771-0</ArticleId><ArticleId IdType="pmc">PMC7990981</ArticleId><ArticleId IdType="pubmed">33761019</ArticleId></ArticleIdList></Reference><Reference><Citation>Poloni TE, Medici V, Moretti M, Vison&#xe0; SD, Cirrincione A, Carlos AF, et al. COVID&#x2010;19&#x2010;related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol [Internet]. 2021 [cited 2022 Jun 28];31. Available from: https://onlinelibrary.wiley.com/doi/10.1111/bpa.12997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412067</ArticleId><ArticleId IdType="pubmed">34145669</ArticleId></ArticleIdList></Reference><Reference><Citation>Mairal E, Doyen M, Rivasseau-Jonveaux T, Malaplate C, Guedj E, Verger A. Clinical impact of digital and conventional PET control databases for semi-quantitative analysis of brain 18F-FDG digital PET scans. EJNMMI Res. 2020;10:144. doi: 10.1186/s13550-020-00733-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13550-020-00733-y</ArticleId><ArticleId IdType="pmc">PMC7704892</ArticleId><ArticleId IdType="pubmed">33258085</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolin S, Chakales A, Verduzco-Gutierrez M. Rehabilitation strategies for cognitive and neuropsychiatric manifestations of COVID-19. Curr Phys Med Rehabil Rep [Internet]. 2022 [cited 2022 Jun 28]; Available from: https://link.springer.com/10.1007/s40141-022-00352-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107067</ArticleId><ArticleId IdType="pubmed">35602927</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain P, Chaney AM, Carlson ML, Jackson IM, Rao A, James ML. Neuroinflammation PET imaging: current opinion and future directions. J Nucl Med Off Publ Soc Nucl Med. 2020;61:1107&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413228</ArticleId><ArticleId IdType="pubmed">32620705</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W-W, Zhang X, Huang W-J. Role of neuroinflammation in neurodegenerative diseases (Review) Mol Med Rep. 2016;13:3391&#x2013;3396. doi: 10.3892/mmr.2016.4948.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.4948</ArticleId><ArticleId IdType="pmc">PMC4805095</ArticleId><ArticleId IdType="pubmed">26935478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, et al. Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. 2021;10:386. doi: 10.3390/cells10020386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez-Guerrero A, Laespada-Garc&#xed;a MI, G&#xf3;mez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ, et al. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020;95:e2109&#x2013;e2118. doi: 10.1212/WNL.0000000000010282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010282</ArticleId><ArticleId IdType="pubmed">32641525</ArticleId></ArticleIdList></Reference><Reference><Citation>Morassi M, Palmerini F, Nici S, Magni E, Savelli G, Guerra UP, et al. SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients. J Neurol. 2021;268:3980&#x2013;3987. doi: 10.1007/s00415-021-10560-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10560-3</ArticleId><ArticleId IdType="pmc">PMC8059684</ArticleId><ArticleId IdType="pubmed">33884450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R, et al. A case of probable Parkinson&#x2019;s disease after SARS-CoV-2 infection. Lancet Neurol. 2020;19:804&#x2013;805. doi: 10.1016/S1474-4422(20)30305-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30305-7</ArticleId><ArticleId IdType="pmc">PMC7494295</ArticleId><ArticleId IdType="pubmed">32949534</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;1276. doi: 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Morbelli S, Kaphan E, Campion J-Y, Dudouet P, Ceccaldi M, et al. From early limbic inflammation to long COVID sequelae. Brain. 2021;144:e65&#x2013;e65. doi: 10.1093/brain/awab215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab215</ArticleId><ArticleId IdType="pubmed">34142116</ArticleId></ArticleIdList></Reference><Reference><Citation>Backer V, Sj&#xf6;bring U, Sonne J, Weiss A, Hostrup M, Johansen HK, et al. A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: a broad spectrum antiviral candidate for treatment of COVID-19. Lancet Reg Health - Eur. 2021;4:100084. doi: 10.1016/j.lanepe.2021.100084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100084</ArticleId><ArticleId IdType="pmc">PMC8021896</ArticleId><ArticleId IdType="pubmed">33842908</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>